India Epilepsy Devices Market

ID: MRFR/HC/48247-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026
India Epilepsy Devices Market Research Report By Product Type (Conventional Devices, Wearable Devices, Implantable Devices, Diet, Others), By Technology (Vagus Nerve Stimulation, Deep Brain Stimulation, Accelerometery, Responsive Neurostimulation, Others), and By End Users (Hospitals and Clinics, Neurology Centers, Home Care Settings, Others) -Forecast to 2035
India Epilepsy Devices Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.0%
2024 Market Size$ 39.5 Million
2025 Market Size$ 41.87 Million
2035 Market Size$ 75 Million
Key Players
Medtronic
Abbott
Boston Scientific
NeuroPace
LivaNova
Natus Medical
Opportunities
  • Rising Prevalence of Epilepsy
  • Growing Awareness and Education
  • Increased Healthcare Expenditure
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Chemicals and Materials, BY Product Type (USD Million)
      1. 4.1.1 Conventional Devices
      2. 4.1.2 Wearable Devices
      3. 4.1.3 Implantable Devices
      4. 4.1.4 Diet
      5. 4.1.5 Others
    2. 4.2 Chemicals and Materials, BY Technology (USD Million)
      1. 4.2.1 Vagus Nerve Stimulation
      2. 4.2.2 Deep Brain Stimulation
      3. 4.2.3 Accelerometery
      4. 4.2.4 Responsive Neurostimulation
      5. 4.2.5 Others
    3. 4.3 Chemicals and Materials, BY End User (USD Million)
      1. 4.3.1 Hospitals and Clinics
      2. 4.3.2 Neurology Centers
      3. 4.3.3 Home Care Settings
      4. 4.3.4 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Abbott (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Boston Scientific (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 NeuroPace (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 LivaNova (GB)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Natus Medical (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 ElectroCore (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Zywave (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 INDIA MARKET ANALYSIS BY PRODUCT TYPE
    3. 6.3 INDIA MARKET ANALYSIS BY TECHNOLOGY
    4. 6.4 INDIA MARKET ANALYSIS BY END USER
    5. 6.5 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
    6. 6.6 RESEARCH PROCESS OF MRFR
    7. 6.7 DRO ANALYSIS OF CHEMICALS AND MATERIALS
    8. 6.8 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    9. 6.9 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    10. 6.10 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
    11. 6.11 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 (% SHARE)
    12. 6.12 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    13. 6.13 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 (% SHARE)
    14. 6.14 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
    15. 6.15 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
    16. 6.16 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
    17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
      3. 7.2.3 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

India Epilepsy Devices Market Segmentation

India Epilepsy Devices Market By Product Type (USD Million, 2025-2035)

  • Conventional Devices
  • Wearable Devices
  • Implantable Devices
  • Diet
  • Others

India Epilepsy Devices Market By Technology (USD Million, 2025-2035)

  • Vagus Nerve Stimulation
  • Deep Brain Stimulation
  • Accelerometery
  • Responsive Neurostimulation
  • Others

India Epilepsy Devices Market By End User (USD Million, 2025-2035)

  • Hospitals and Clinics
  • Neurology Centers
  • Home Care Settings
  • Others
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.